Clomiphene, is a prescription medication that promotes ovulation in women. It is mainly used for women with ovulation disorders or non-ovulation in women with infertility, as well as for a small number of people who are infertile due to irregular menstruation. However, if clomiphene is abused by normal women, it may lead to premature ovarian failure, early menopause, and also a high risk of ovarian hyperstimulation syndrome. It should be used under medical supervision even in infertile women. What is there to know about clomiphene? The scientific name for polyclomiphene is clomiphene, a prescription medication that promotes ovulation in women. It is used by a small group of infertile women who have ovulation disorders or are not ovulating, and those who are infertile due to irregular menstruation. These patients can produce more than two eggs a month after taking ovulation-promoting drugs under medical supervision. When these eggs are combined with sperm, multiple fertilized eggs will be formed and will develop into multiple births, thus increasing the chances of pregnancy in infertility patients. However, care should be taken not to overdose and to monitor the number of expelled follicles to prevent the development of too many follicles, which can lead to multiple pregnancies. In addition, there are some people who are particularly sensitive to ovulation-promoting drugs and taking them may cause an unusually large number of follicles to be expelled. Generally, doctors will strictly control the dosage of ovulation-promoting drugs to ensure that patients ovulate between one and four eggs at a time. Therefore, it is important that such prescription ovulation-promoting drugs are taken under the guidance of a doctor. Women of normal reproductive age who abuse clomiphene are likely to experience adverse consequences. Because clomiphene promotes the maturation and development of follicles, improper administration can easily lead to endocrine disorders. Generally speaking, women discharge one mature egg every month. Using ovulation-promoting drugs to induce ovarian ovulation can lead to premature ovarian failure and early menopause, as well as to ovarian hyperstimulation syndrome, such as dizziness, nausea, and impairment of liver and kidney function. From the perspective of healthy fertility, the risks of multiple pregnancies are inherently higher. Multiple pregnancies are more prone to miscarriage and preterm delivery than singleton pregnancies, and pregnant women are more likely to suffer from gestational hypertension and anemia, as well as excessive amniotic fluid and premature rupture of membranes. In case of 3 to 5 pregnancies, the chance of very low birth weight babies (birth weight <1.5 kg) is also greatly increased. Due to the limited space in the maternal uterine cavity, the growth and development of the fetus will also be affected, and in severe cases, the fetus will be too small and lack essential trace elements, such as iron and calcium. Tips: Both infertile and normal women should be cautious about ovulation-promoting drugs and should not buy and take them at will. It is not recommended for healthy women to get pregnant in this way.